Benutzer: Gast  Login
Titel:

[Reliability and safety of intravitreal Ozurdex injections. The ZERO study].

Dokumenttyp:
English Abstract; Journal Article; Multicenter Study; Observational Study; Article
Autor(en):
Schmitz, K; Maier, M; Clemens, C R; Höhn, F; Wachtlin, J; Lehmann, F; Bertelmann, T; Rüdiger, K; Horn, M; Bezatis, A; Spital, G; Meyer, C H
Abstract:
Since July 2010 Ozurdex® is approved in Germany for treatment of macular edema from retinal vein occlusion (RVO). The objective of this observational study was a systemic summary and analysis of clinical experience regarding complications and side effects of intravitreal administration of dexamethasone.In a retrospective, multicenter study conducted at 10 centers, 342 eyes with RVO were treated with intravitreal dexamethasone (Ozurdex®, Allergan). After treatment the patients were followed-up ov...     »
Zeitschriftentitel:
Ophthalmologe
Jahr:
2014
Band / Volume:
111
Heft / Issue:
1
Seitenangaben Beitrag:
44-52
Sprache:
de
Volltext / DOI:
doi:10.1007/s00347-012-2737-2
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/23559321
Print-ISSN:
0941-293X
TUM Einrichtung:
Klinik und Poliklinik für Augenheilkunde
 BibTeX